{
    "title": "Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12362339/Vertex-Pharma-raises-year-revenue-forecast-cystic-fibrosis-treatment-strength.html",
    "date": "2023-08-01",
    "keywords": [
        "drug",
        "forecast",
        "fibrosis",
        "cf",
        "treatment",
        "company",
        "quarter",
        "year",
        "disorder",
        "sickle",
        "cell",
        "disease",
        "pain",
        "share",
        "banking",
        "demand",
        "drugmaker",
        "rise",
        "beat",
        "uptake",
        "trikafta",
        "estimate",
        "trifakta",
        "damage",
        "system",
        "companys",
        "therapy",
        "crispr",
        "review",
        "health",
        "administration",
        "regulator",
        "decision",
        "dec",
        "approval",
        "nobel",
        "technology",
        "blood",
        "transfusiondependent",
        "beta",
        "thalassemia",
        "vertex",
        "vx548",
        "acute",
        "profit",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "pooja",
        "desai"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}